Match!
Journal of Clinical Oncology
IF
28.25
Papers
106462
Papers 106408
1 page of 10.6k pages (106k results)
Newest
#1Julie DelyonH-Index: 5
#2Nelson LourencoH-Index: 4
Last.Celeste LebbeH-Index: 48
view all 6 authors...
Source
#1Sven Borchmann (University of Cologne)H-Index: 3
#2Melita Cirillo (University of Cologne)
Last.Andreas Engert (University of Cologne)H-Index: 78
view all 11 authors...
PURPOSEVitamin D deficiency is described as a modifiable risk factor for the incidence of and mortality in many common cancers; however, data in Hodgkin lymphoma (HL) are lacking.PATIENTS AND METHO...
Source
#1Priyanka Sharma (KU: University of Kansas)H-Index: 19
#2William E. BarlowH-Index: 64
Last.Daniel F. Hayes (UM: University of Michigan)H-Index: 106
view all 22 authors...
PURPOSETo independently validate two biomarkers, a 44-gene DNA damage immune response (DDIR) signature and stromal tumor-infiltrating lymphocytes (sTILs), as prognostic markers in patients with tri...
1 CitationsSource
#1Hamzah Abu-SbeihH-Index: 6
#2Faisal S. AliH-Index: 4
Last.Yinghong WangH-Index: 9
view all 6 authors...
Source
Source
#1Emmanouil Fokas (Goethe University Frankfurt)H-Index: 27
#2Claus Rödel (Goethe University Frankfurt)H-Index: 36
Source
Source
PURPOSEResponse to programmed cell death protein 1 (PD-1) blockade is often conceptualized as resulting from reinvigoration of tumor-infiltrating lymphocytes. However, recruited antitumor immunity ...
Source
PURPOSESix-transmembrane epithelial antigen of the prostate 1 (STEAP1) is highly expressed in prostate cancers. DSTP3086S is a humanized immunoglobulin G1 anti-STEAP1 monoclonal antibody linked to ...
Source
PURPOSEPatients with acute myeloid leukemia (AML) in remission remain at risk for relapse even after allogeneic hematopoietic cell transplantation (alloHCT). AML measurable residual disease (MRD) s...
Source
12345678910
Top fields of study
Cancer
Pathology
Oncology
Chemotherapy
Medicine